This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Sign In   |   Register


EAS has pioneered guidelines on the prevention of cardiovascular disease with pan-European campaigns in 1987 and 1988. Recognizing that guidelines endorsed by cardiologists would have greater impact on clinical practice, the EAS joined forces with the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH) to issue the first set of joint European Guidelines on Prevention of Coronary Artery Disease in 1994. This collaboration has been expanded over the years.

Current Guidelines

Cardiovascular Disease Prevention in Clinical Practice

The Joint 2016 European Guidelines on Cardiovascular Disease Prevention in Clinical Practice, is a collaboration by 10 professional societies.

Guidelines on Management of Dyslipidaemia

EAS has collaborated with the European Society of Cardiology to publish joint guidelines on management of dyslipidaemias in 2011, which were updated August 2016.

On August 31st 2019, the 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk, were published. These novel ESC/EAS Guidelines on lipids provide important new advice on patient management, which should enable more clinicians to efficiently and safely reduce CV risk through lipid modification.

Membership Software Powered by YourMembership  ::  Legal